cash flow reconciliationreview2026-06-30
Operating, investing and financing flows differ from the reported change in cash by 17000000, beyond tolerance 2900000.00.
Revenue
$2.34B
Fiscal year ended 2026-06-30Operating income
$390.00M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Xylem Inc. (XYL) reported revenue of $2.34B and net income of $263.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Xylem Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pumps & Pumping Equipment.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.34B | $2.12B | $2.40B | $2.27B | $2.30B | $2.07B | $2.35B | $2.10B | $2.17B | $2.03B |
| Cost of revenue | $1.37B | $1.32B | $1.46B | $1.38B | $1.41B | $1.30B | $1.40B | $1.32B | $1.35B | $1.28B |
| Gross profit | $963.00M | $803.00M | $932.00M | $883.00M | $892.00M | $768.00M | $857.00M | $784.00M | $819.00M | $752.00M |
| Operating income | $390.00M | $244.00M | $353.00M | $334.00M | $305.00M | $231.00M | $267.00M | $280.00M | $253.00M | $209.00M |
| Net income | $263.00M | $193.00M | $335.00M | $227.00M | $226.00M | $169.00M | $326.00M | $217.00M | $194.00M | $153.00M |
| Research & development | $59.00M | $56.00M | $60.00M | $52.00M | $58.00M | $56.00M | $58.00M | $55.00M | $58.00M | $59.00M |
| Weighted-average diluted shares | shares 236.57M | shares 243.36M | Unavailable | shares 244.09M | shares 243.86M | shares 243.78M | Unavailable | shares 243.75M | shares 243.54M | shares 243.02M |
| Pretax income | $364.00M | $244.00M | Unavailable | $297.00M | $299.00M | $217.00M | Unavailable | $269.00M | $247.00M | $196.00M |
| Income tax expense | $103.00M | $55.00M | $35.00M | $71.00M | $75.00M | $50.00M | $49.00M | $52.00M | $53.00M | $43.00M |
| Diluted EPS | $1.11 | $0.79 | Unavailable | $0.93 | $0.93 | $0.69 | Unavailable | $0.89 | $0.80 | $0.63 |
| Selling, general & administrative | $503.00M | $472.00M | $486.00M | $474.00M | $503.00M | $460.00M | $507.00M | $445.00M | $485.00M | $474.00M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.28B | $808.00M | $1.48B | $1.19B | $1.17B | $1.06B | $1.12B | $989.00M | $815.00M | $947.00M |
| Total assets | $17.34B | $16.95B | $17.63B | $17.30B | $17.19B | $16.56B | $16.49B | $16.05B | $15.76B | $15.92B |
| Current assets | $4.39B | $4.03B | $4.64B | $4.44B | $4.37B | $4.08B | $4.10B | $4.01B | $3.78B | $3.89B |
| Total liabilities | $6.68B | $5.72B | $5.88B | $5.85B | $5.88B | $5.50B | $5.61B | $5.45B | $5.42B | $5.72B |
| Current liabilities | $2.72B | $2.76B | $2.86B | $2.27B | $2.30B | $2.17B | $2.34B | $2.05B | $2.04B | $2.33B |
| Total equity incl. NCI | $10.42B | $10.98B | $11.49B | $11.22B | $11.08B | $10.82B | $10.65B | $10.60B | $10.35B | $10.20B |
| Temporary (mezzanine) equity | $242.00M | $249.00M | $258.00M | $226.00M | $228.00M | $232.00M | $235.00M | Unavailable | Unavailable | Unavailable |
| Inventory | $1.02B | $991.00M | $983.00M | $1.04B | $1.07B | $1.02B | $996.00M | $1.09B | $1.06B | $1.04B |
| Accounts receivable | $1.88B | $1.80B | $1.76B | $1.80B | $1.84B | $1.74B | $1.67B | $1.71B | $1.68B | $1.64B |
| Goodwill | $8.26B | $8.29B | $8.33B | $8.28B | $8.24B | $8.06B | $7.98B | $7.59B | $7.51B | $7.51B |
| Long-term debt | $2.40B | $1.41B | $1.41B | $1.91B | $1.93B | $1.97B | $1.98B | $1.98B | $1.98B | $1.98B |
| Accounts payable | $1.01B | $969.00M | $1.01B | $968.00M | $1.05B | $958.00M | $1.01B | $930.00M | $940.00M | $948.00M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $290.00M | $108.00M | $543.00M | $360.00M | $305.00M | $33.00M | $575.00M | $311.00M | $288.00M | $89.00M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$22.00M | -$76.00M | -$142.00M | -$189.00M | -$125.00M | -$15.00M | -$289.00M | -$65.00M | -$77.00M | -$51.00M |
| Financing cash flow | $199.00M | -$683.00M | -$119.00M | -$138.00M | -$128.00M | -$116.00M | -$95.00M | -$101.00M | -$337.00M | -$82.00M |
| Net change in cash | $468.00M | -$671.00M | $288.00M | $21.00M | $111.00M | -$62.00M | $132.00M | $174.00M | -$132.00M | -$72.00M |
| Stock-based compensation | $12.00M | $13.00M | $16.00M | $12.00M | $13.00M | $12.00M | $13.00M | $12.00M | $13.00M | $18.00M |
| Common dividends paid | $101.00M | $106.00M | $98.00M | $97.00M | $98.00M | $98.00M | $87.00M | $88.00M | $87.00M | $88.00M |
| Common share repurchases | $680.00M | $563.00M | $1.00M | $1.00M | $0 | $13.00M | $1.00M | $1.00M | $3.00M | $15.00M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $142.00M | $141.00M | $145.00M | $134.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 41.2% | 37.8% | 38.9% | 38.9% | 38.8% | 37.1% | 36.4% | 37.3% | 37.8% | 37.0% |
| Operating margin | 16.7% | 11.5% | 14.7% | 14.7% | 13.3% | 11.2% | 11.3% | 13.3% | 11.7% | 10.3% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.5% | 0.6% | 0.7% | 0.5% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.9% |
| Current ratio | 1.61x | 1.46x | 1.62x | 1.96x | 1.90x | 1.89x | 1.75x | 1.96x | 1.85x | 1.67x |
| Revenue YoY growth | 1.5% | 2.7% | 1.9% | 7.8% | 6.1% | 1.8% | 18.1% | 1.3% | 26.0% | 40.4% |
| Net margin | 11.3% | Unavailable | 14.0% | 10.0% | 9.8% | Unavailable | 13.9% | 10.3% | Unavailable | Unavailable |
| R&D / revenue | 2.5% | 2.6% | 2.5% | 2.3% | 2.5% | 2.7% | 2.5% | 2.6% | 2.7% | 2.9% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.23x | Unavailable | 0.12x | 0.17x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 28.3% | 22.5% | Unavailable | 23.9% | 25.1% | 23.0% | Unavailable | 19.3% | 21.5% | 21.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open XYL in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-28View SEC filing
10-Q · Filed 2026-04-28View SEC filing
10-K · Filed 2026-02-25View SEC filing
10-Q · Filed 2025-10-28View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-04-29View SEC filing
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2025-09-30
Operating, investing and financing flows differ from the reported change in cash by 11000000, beyond tolerance 3600000.00.
cash flow reconciliationreview2025-03-31
Operating, investing and financing flows differ from the reported change in cash by 11000000, beyond tolerance 1160000.00.
cash flow reconciliationreview2024-12-31
Operating, investing and financing flows differ from the reported change in cash by 11000000, beyond tolerance 5750000.00.
balance equationreview2022-09-30
Difference 367000000 exceeds tolerance 8106000.000. Presentation or filing-vintage differences need review.